New from #wellcometrust https://t.co/JIUXIZfsdB Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium
New from #ERC_Research https://t.co/JIUXIZfsdB Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl – Discovery of biomarkers for glycaemic deterioration before and after the onset of ty…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl – Discovery of biomarkers for glycaemic deterioration before and after the onset of ty…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl – Discovery of biomarkers for glycaemic deterioration before and after the onset of ty…
RT @ClinMedJournals: #OpenAccess in @DiabetologiaJnl – Discovery of biomarkers for glycaemic deterioration before and after the onset of ty…
#OpenAccess in @DiabetologiaJnl – Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium https://t.co/pMHBrMMOad https:/
RT @DiabetologiaJnl: IMI DIRECT cohorts to facilitate the discovery of biomarkers for glycaemic control in individuals at risk of- or with…
Have a first look at some data and descriptions of our new prospective cohorts for #T2D #biomarker discovery and stay posted for exciting stuff on the horizon using this data. A big thank you to all IMI DIRECT participants and @DIRECTdiabetes collaborators
RT @DiabetologiaJnl: IMI DIRECT cohorts to facilitate the discovery of biomarkers for glycaemic control in individuals at risk of- or with…
RT @DiabetologiaJnl: IMI DIRECT cohorts to facilitate the discovery of biomarkers for glycaemic control in individuals at risk of- or with…
IMI DIRECT cohorts to facilitate the discovery of biomarkers for glycaemic control in individuals at risk of- or with type 2 diabetes. #personalizedmedicine #T2D @IMI_JU @EFPIA @DIRECTdiabetes https://t.co/MwQPp7A3An 🔓 https://t.co/QGz5Frdqqu
RT @LifeSciWestmin: Well done to @ImagingFat and Prof Jimmy Bell from the @RCOptimalHealth team. Great to see this interesting work publish…
RT @RCOptimalHealth: Delighted to see our collaborative research relating to biomarkers of glycaemic deterioration before and after the ons…
Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium. https://t.co/gaEBMwdLRz
RT @RCOptimalHealth: Delighted to see our collaborative research relating to biomarkers of glycaemic deterioration before and after the ons…
RT @MSA_health: Well done @RCOptimalHealth 👏👏👏 https://t.co/MPgYt68eJk
RT @LifeSciWestmin: Well done to @ImagingFat and Prof Jimmy Bell from the @RCOptimalHealth team. Great to see this interesting work publish…
Well done @RCOptimalHealth 👏👏👏
Well done to @ImagingFat and Prof Jimmy Bell from the @RCOptimalHealth team. Great to see this interesting work published in @DiabetologiaJnl today.
RT @RCOptimalHealth: Delighted to see our collaborative research relating to biomarkers of glycaemic deterioration before and after the ons…
Delighted to see our collaborative research relating to biomarkers of glycaemic deterioration before and after the onset of type 2 diabetes with the DIRECT IMI Consortium published in @DiabetologiaJnl today https://t.co/QOV9s9arRI @ImagingFat @LifeSciWestm